Trapelo
How can we resolve the complexities of using precision medicine for cancer care? Trapelo knows.
How can we resolve the complexities of using precision medicine for cancer care? Trapelo knows.
Trapelo is a healthcare and IT startup founded in 2009 in the United States. The company offers a pioneering technology platform, Trapelo™, dedicated to fostering precision medicine in cancer care. By aligning the interests of oncologists, molecular labs, and payers, Trapelo aims to provide real-time, evidence-based information and full transparency for better patient-based decisions. The company's slogan, "How can we resolve the complexities of using precision medicine for cancer care? Trapelo knows," encapsulates its mission. With a recent $4.16M Venture Round investment in November 2017, Trapelo is poised to further its impact in the healthcare industry. By facilitating network-wide collaboration, the company aims to streamline and optimize molecular testing for cancer care. Visit GetTrapelo.com to schedule a demo or get in touch with the company at 617.250.7572 or [email protected].
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $4.16M | - | 08 Nov 2017 | |
| Venture Round | $3.50M | 1 |
|
09 Jul 2014 |
No recent news or press coverage available for Trapelo.
We care about your data, and we'd love to use cookies make your experience better.
